6 April 2017 (Thursday) - The Oncologist

The nice people at Wiley emailed today with a ton of papers including:

Best Practices in Chronic Myeloid Leukemia Monitoring and Management Simona Soverini, Caterina De Benedittis, Manuela Mancini, Giovanni Martinelli May 2016 (Volume 21:5) Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option? Patrizia Mondello, Normann Steiner, Wolfgang Willenbacher et al. September 2016 (Volume 21:9) Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3) Sunil Verma, Cynthia Huang Bartlett, Patrick Schnell et al October 2016 (Volume 21:10) Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non-Small Cell Lung Cancer and the Role of Biopsy at Progression Mark A. Socinski, Liza C. Villaruz, Jeffrey Ross January 2017 (Volume 22:1)

Also look for these forthcoming papers in future issues: The Incidence and Healthcare Resource Burden of the Myelodysplastic Syndromes in Patients in Whom 1st-Line Hypomethylating Agents Fail Christopher R. Cogle, Sandra Kurtin, Tanya G. Bentley et al. Risk-reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act Annekathryn Goodman, Roi Tschernichovsky Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Non-Pegylated Liposomal Doxorubicin Jacopo Olivieri, Gian Piero Perna et al. Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma Michael Wang, Makhdum Ahmed, Aakash Desai et al. Systemic Treatment Strategies for Patients with Hereditary Breast Cancer Syndromes Jennifer K Litton, Amanda Parkes, Banu Arun

They also offered me a free subscription to “The Oncologist”. Regular CPD emails  is always a good thing.